Telomir Pharmaceuticals grants director 50,000 stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Telomir Pharmaceuticals, Inc. reported that director Edward Clouston MacPherson received a grant of 50,000 non-qualified stock options on April 16, 2026. The options have an exercise price of $1.34 per share, vested immediately, expire on April 16, 2036, and represent 50,000 options held directly after the grant.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualified Stock Options (right to buy) F1, F2 | 50,000 | $0.00 | $0.00 |
Footnotes (2)
- F1. The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on April 16, 2026.
- F2. The stock options were issued to the Reporting Person on April 16, 2026, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). All of the options vested immediately upon issuance.
Key Figures
Key Terms
Non-Qualified Stock Options (right to buy) financial
exercise price financial
2023 Omnibus Incentive Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Telomir Pharmaceuticals (TELO) report for Edward Clouston MacPherson?
How many Telomir (TELO) stock options were granted and at what exercise price?
When do the Telomir Pharmaceuticals (TELO) stock options granted to MacPherson expire?
Under which plan were the Telomir (TELO) options granted and when did they vest?
Did the Telomir Pharmaceuticals (TELO) Form 4 report any stock sales by MacPherson?
What is MacPherson’s Telomir (TELO) option holding after this reported grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.